These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 22976575

  • 1. Management of gastric carcinoids (neuroendocrine neoplasms).
    Kidd M, Gustafsson BI.
    Curr Gastroenterol Rep; 2012 Dec; 14(6):467-72. PubMed ID: 22976575
    [Abstract] [Full Text] [Related]

  • 2. Gastric Carcinoids.
    Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G.
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
    [Abstract] [Full Text] [Related]

  • 3. Gastric carcinoids (neuroendocrine neoplasms).
    Kidd M, Gustafsson B, Modlin IM.
    Gastroenterol Clin North Am; 2013 Jun; 42(2):381-97. PubMed ID: 23639647
    [Abstract] [Full Text] [Related]

  • 4. A clinical perspective on gastric neuroendocrine neoplasia.
    Lawrence B, Kidd M, Svejda B, Modlin I.
    Curr Gastroenterol Rep; 2011 Feb; 13(1):101-9. PubMed ID: 21080245
    [Abstract] [Full Text] [Related]

  • 5. Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy?
    Senadhi V, Jani N.
    World J Gastroenterol; 2011 Sep 21; 17(35):4052-4. PubMed ID: 22046097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
    Akerström G.
    World J Surg; 1996 Feb 21; 20(2):173-82. PubMed ID: 8661814
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.
    Hoshino M, Omura N, Yano F, Tsuboi K, Matsumoto A, Yamamoto SR, Akimoto S, Kashiwagi H, Yanaga K.
    Hepatogastroenterology; 2010 Feb 21; 57(98):379-82. PubMed ID: 20583448
    [Abstract] [Full Text] [Related]

  • 10. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.
    Borch K, Ahrén B, Ahlman H, Falkmer S, Granérus G, Grimelius L.
    Ann Surg; 2005 Jul 21; 242(1):64-73. PubMed ID: 15973103
    [Abstract] [Full Text] [Related]

  • 11. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM.
    Am J Gastroenterol; 1995 Mar 21; 90(3):338-52. PubMed ID: 7872269
    [Abstract] [Full Text] [Related]

  • 12. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML, Gauger P, Thompson NW, Giordano TJ.
    World J Surg; 2004 Jul 21; 28(7):652-8. PubMed ID: 15383867
    [Abstract] [Full Text] [Related]

  • 13. Modern Management of Gastric Neuroendocrine Neoplasms.
    Kunstman JW, Nagar A, Gibson J, Kunz PL.
    Curr Treat Options Oncol; 2024 Sep 21; 25(9):1137-1152. PubMed ID: 39083164
    [Abstract] [Full Text] [Related]

  • 14. Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Sundaresan S, Kang AJ, Hayes MM, Choi EK, Merchant JL.
    Gut; 2017 Jun 21; 66(6):1012-1021. PubMed ID: 26860771
    [Abstract] [Full Text] [Related]

  • 15. Review article: the investigation and management of gastric neuroendocrine tumours.
    Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK.
    Aliment Pharmacol Ther; 2014 May 21; 39(10):1071-84. PubMed ID: 24628514
    [Abstract] [Full Text] [Related]

  • 16. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
    Campana D, Ravizza D, Ferolla P, Faggiano A, Grimaldi F, Albertelli M, Berretti D, Castellani D, Cacciari G, Fazio N, Colao A, Ferone D, Tomassetti P.
    Endocrine; 2016 Jan 21; 51(1):131-9. PubMed ID: 25814125
    [Abstract] [Full Text] [Related]

  • 17. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
    Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, Santini D, Tomassetti P, Brandi ML.
    Am J Surg Pathol; 1997 Sep 21; 21(9):1075-82. PubMed ID: 9298884
    [Abstract] [Full Text] [Related]

  • 18. Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
    Rossi RE, Invernizzi P, Mazzaferro V, Massironi S.
    United European Gastroenterol J; 2020 Mar 21; 8(2):140-147. PubMed ID: 32213066
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine neoplasms of the stomach.
    Louthan O.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep 21; 158(3):455-60. PubMed ID: 23817299
    [Abstract] [Full Text] [Related]

  • 20. Gastric carcinoids: Does type of surgery or tumor affect survival?
    Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG.
    Am J Surg; 2019 May 21; 217(5):937-942. PubMed ID: 30686481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.